Garner Health, an AI-powered care navigation platform backed by Sequoia Capital and other major venture firms, closed a $100 million Series E round at a $2.74 billion valuation on May 28, 2026. The New York-based employer healthcare startup has now raised roughly $300 million in total funding, capping a $218 million fundraising sprint over three months.

The round was led by Index Ventures, with participation from existing backers including Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund, and Kaiser Permanente Ventures. The unusually concentrated syndicate signals confidence in Garner's core thesis: that artificial intelligence can identify high-performing physicians and nudge employees toward them, resulting in measurable cost savings for large employers.

How Does Garner's AI Platform Actually Work?

• Data Scale: Garner analyzes a database of over 60 billion medical records covering 320 million patients to evaluate providers using 550 proprietary clinical metrics.
• Provider Scoring: The platform assigns quality scores to physicians based on clinical outcomes, then uses employer-funded financial incentives to steer members toward those high-performing providers.
• Member Engagement: Approximately 46% of eligible members actively use the system, a usage rate that outpaces most point solutions in the healthcare market.

The company reports serving nearly 800 employer and partner clients, reaching about 2.5 million members across the United States. Major customers include USA Today, Paylocity, the University of Oklahoma, and Archer-Daniels-Midland, which recently signed on with 44,000 employees.

What Results Are Employers Actually Seeing?

Garner claims employers using the platform see an average 12% reduction in total healthcare spend during the first year of use. This cost containment occurs without disrupting existing provider networks, a key selling point for large enterprises hesitant to overhaul their healthcare arrangements.

The company's valuation reflects investor confidence in this model. At $2.74 billion, Garner is valued at roughly 14 times its estimated $200 million in annual recurring revenue (ARR), a premium pegged to its AI-enabled provider scoring capabilities. The platform has doubled its ARR year-over-year for five consecutive periods, a metric institutional investors now closely underwrite.

The timing of this funding round reflects broader momentum in digital health. In the first quarter of 2026, digital health startups raised $4 billion in venture capital, up $1 billion from the same quarter the previous year and marking the strongest first quarter since the pandemic peak. However, capital concentration is pronounced: just 12 companies captured 59% of total quarterly funding through deals of $100 million or more. Garner is now the second consecutive quarter where it has cleared that threshold.

Why Is Sequoia Betting on Healthcare AI Now?

Sequoia's participation in this round reflects a broader venture capital pivot toward healthcare organizations that can demonstrate both clinical credibility and financial returns. Companies with FDA clearances, HIPAA-compliant infrastructure, and existing payer contracts command materially higher valuations than startups with simply "AI-enabled" in their pitch deck and no clear path to reimbursement.

Garner's differentiator is data scale combined with measurable employer outcomes. The company parses medical records across a massive patient population and routes members to providers using proprietary clinical metrics, creating a feedback loop that improves over time. This positions Garner in a new procurement category for HR and benefits leaders: provider intelligence, alongside traditional point-of-care solutions and pharmacy benefit managers.

The Series E capital is earmarked for AI product expansion, including a Research Agent and a member-facing Assistant, both powered by the company's 60-billion-record claims database and 550 proprietary clinical metrics. These tools are designed to deepen engagement and provide employers with more granular insights into provider performance and member health trends.

Garner has not announced an IPO date, but the company ran a second employee tender offer alongside the Series E, a step companies typically take to provide liquidity ahead of a possible public listing. If the pace of mega-deals in digital health continues, 2026 could end with 50 rounds worth $100 million or more, according to Rock Health data cited in the source material.